BioTime, Inc. , a leader in developing pluripotent stem-cell therapies and other technologies designed to address major unmet medical needs, today announced the appointment of Adi Mohanty to the position of Chief Operating Officer of the Company. Mr. Mohanty's primary responsibilities will be to build BioTime's business through the development of its subsidiaries and through the further development and commercialization of BioTime's HyStem "The addition of Adi to our senior management team is another execution milestone for BioTime as we broaden our capabilities to address market opportunities and build shareholder value," said Dr. West.
http://www.freshnews.com/news/1028660/biotime-appoints-adi-mohanty-chief-operating-officer
http://www.freshnews.com/news/1028660/biotime-appoints-adi-mohanty-chief-operating-officer
No comments:
Post a Comment